Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Bet on These 5 Low Leverage Stocks This Earnings Season

Published 08/02/2020, 10:00 PM
Updated 07/09/2023, 06:31 AM

Companies often need exogenous funds to ensure smooth operations and expansion of business. These funds can be arranged through debt and equity. Here comes the concept of leverage, which is basically borrowing of funds for such purposes.

This borrowing can be done through equity or debt financing.

Now, the theory of cost reveals that most companies prefer debt financing over equity since debt is cheaper, especially in periods of low interest rates. This is because when a company resorts to debt financing, it takes on fixed expenses in the form of interest payments for a specific time period.

The current market situation seems favorable for corporates to take debt since the COVID-19 pandemic has forced the Federal Reserve to lower interest rate to a near-zero level.

Yet, debt is something that gives you the chills since it brings with it the burden of repayment with additional interest in the future.

Especially, in times of crisis like the ongoing one, no one can be fully sure of how a company will perform. On top of that, those bearing large amount of debt are even more prone to bankruptcy.

Therefore, to safeguard one’s portfolio from notable losses, the real challenge for an investor is determining whether the organization’s debt level is sustainable. A debt-free corporation is rare to find. Historically several leverage ratios have been developed to measure the amount of debt a company bears and the debt-to-equity ratio is one of the most common ratios.

Analyzing Debt/Equity

Debt-to-Equity Ratio = Total Liabilities/Shareholders’ Equity

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This metric is a liquidity ratio that indicates the amount of financial risk a company bears. A company with a lower debt-to-equity ratio shows improved solvency for a company.

With the Q2 reporting cycle in full swing right now, investors may choose companies that are exhibiting solid earnings growth. However, blindly pursuing high earnings yielding stocks, which have a high debt-to-equity ratio, might drain all your money before you know.

The Winning Strategy

Considering the aforementioned factors, it is prudent to choose stocks with a low debt-to-equity ratio to ensure steady returns.

However, an investment strategy based solely on debt-to-equity ratio might not fetch the desired outcome. To choose stocks that have the potential to give you steady returns, we have expanded our screening criteria to include some other factors.

Here are the other parameters:

Debt/Equity less than X-Industry Median: Stocks that are less leveraged than their industry peers.

Current Price greater than or equal to 10: The stocks must be trading at a minimum of $10 or above.

Average 20-day Volume greater than or equal to 50000: A substantial trading volume ensures that the stock is easily tradable.

Percentage Change in EPS F(0)/F(-1) greater than X-Industry Median: Earnings growth adds to optimism, leading to a stock’s price appreciation.

VGM Score of A or B: Our research shows that stocks with a VGM Score of A or B when combined with a Zacks Rank #1 (Strong Buy) or 2 (Buy) offer the best upside potential.

Estimated One-Year EPS Growth F(1)/F(0) greater than 5: This shows earnings growth expectation

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks Rank #1 or 2: Irrespective of market conditions, stocks with a Zacks Rank #1 (Strong Buy) or 2 (Buy) have a proven history of success.

Excluding stocks that have a negative or a zero debt-to-equity ratio, here are five of the 21 stocks that made it through the screen.

Medpace Holdings (NASDAQ:MEDP) MEDP: It is a clinical contract research organization, which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The company delivered an earnings surprise of 18.48%, on average, in the trailing four quarters and currently sports a Zacks Rank #1.

Lakeland Industries (NASDAQ:LAKE) LAKE: It is engaged in the manufacturing of protective clothing to help improve the quality of safety for the industrial workforce. The company currently sports aZacks Rank #1 and delivered an earnings surprise of 722.92% in the trailing four quarters, on average.

The Descartes (NASDAQ:DSGX) Systems Group DSGX: It is a provider of software-as-a-service logistics solutions. The company came up with a four-quarter earnings surprise of 6.94%, on average, and carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.

Piedmont Office (NYSE:PDM) Realty Trust PDM: It is an integrated and self-managed real estate investment trust specializing in the acquisition, ownership, management and development of commercial real estate properties. Currently, the company carries aZacks Rank #2 and came up with a four-quarter earnings surprise of 0.06%, on average.

West Pharmaceutical Services (NYSE:WST) WST: It operates as a global drug delivery technology company. It currently sports a Zacks Rank #1 and delivered a four-quarter earnings surprise of 21.42%, on average.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and back testing software.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Piedmont Office Realty Trust, Inc. (PDM): Free Stock Analysis Report

West Pharmaceutical Services, Inc. (WST): Free Stock Analysis Report

Lakeland Industries, Inc. (LAKE): Free Stock Analysis Report

The Descartes Systems Group Inc. (DSGX): Free Stock Analysis Report

Medpace Holdings, Inc. (MEDP): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.